Physician profile
Michael Ryan Reidy
NPI 1447575964
$3,236.92
in general payments reported to CMS, 2019-2025
30 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $411 · 2021: $358 · 2022: $804 · 2023: $560 · 2024: $431 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,755.78 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Inspiris Resilia Aortic Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $380.05 | 2019-2025 | Lifevest |
| Getinge USA Sales, LLC | $129.45 | 2019-2025 | Vasoview Hemopro 2 |
| Intuitive Surgical, INC. | $89.64 | 2020-2024 | |
| Atricure, INC. | $78.51 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Medistim USA, INC. | $77.37 | 2023 | Miraq |
| Medtronic, INC. | $64.59 | 2021-2022 | |
| Corcym INC | $60.66 | 2022-2025 | Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Abbott Laboratories | $56.56 | 2019-2021 | |
| Silk Road Medical, INC. | $53.98 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Haemonetics Corporation | $51.90 | 2024 | Teg6s Hemostasis System |
| Ethicon US, LLC | $43.79 | 2022 | |
| W. L. Gore & Associates, INC. | $39.29 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Depuy Synthes Sales INC. | $35.68 | 2022 | |
| Abiomed | $32.45 | 2024 | Impella |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $30.64 | 2023 | Sternalock Blu System |
| Kerecis Limited | $28.11 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $24.43 | 2020 | |
| Medela LLC | $22.40 | 2025 | Thopaz |
| Aesculap, INC. | $20.67 | 2019 | |
| Kci USA, INC. | $18.90 | 2020 | |
| Amgen INC. | $17.90 | 2023 | Repatha |
| Bolton Medical INC | $17.90 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.69 | 2021 | |
| Tela Bio, INC. | $17.16 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Philips North America LLC | $16.90 | 2022 | |
| Artivion, INC. | $15.18 | 2020 | |
| Davol INC. | $13.95 | 2023 | Arista Ah Flexitip |
| Elite Orthopedics, LLC | $13.43 | 2023 | |
| Veran Medical Technologies, INC. | $11.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Reidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.